0001209191-23-048441.txt : 20230906
0001209191-23-048441.hdr.sgml : 20230906
20230906171304
ACCESSION NUMBER: 0001209191-23-048441
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210330
FILED AS OF DATE: 20230906
DATE AS OF CHANGE: 20230906
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: William Arsani
CENTRAL INDEX KEY: 0001848372
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40288
FILM NUMBER: 231240085
MAIL ADDRESS:
STREET 1: C/O DESIGN THERAPEUTICS, INC.
STREET 2: 6005 HIDDEN VALLEY ROAD, SUITE 110
CITY: CARLSBAD
STATE: CA
ZIP: 92011
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Design Therapeutics, Inc.
CENTRAL INDEX KEY: 0001807120
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 823929248
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6005 HIDDEN VALLEY ROAD
STREET 2: SUITE 110
CITY: CARLSBAD
STATE: CA
ZIP: 92011
BUSINESS PHONE: 858-293-4900
MAIL ADDRESS:
STREET 1: 6005 HIDDEN VALLEY ROAD
STREET 2: SUITE 110
CITY: CARLSBAD
STATE: CA
ZIP: 92011
4/A
1
doc4a.xml
FORM 4/A SUBMISSION
X0508
4/A
2021-03-30
2021-04-01
0
0001807120
Design Therapeutics, Inc.
DSGN
0001848372
William Arsani
C/O DESIGN THERAPEUTICS, INC.
6005 HIDDEN VALLEY ROAD, SUITE 110
CARLSBAD
CA
92011
1
0
0
0
0
Common Stock
2021-03-30
4
C
0
1217627
A
1217627
I
By Logos Opportunities Fund II, L.P.
Common Stock
2021-03-30
4
C
0
814874
A
814874
I
By Logos SPV 1 LP
Common Stock
2021-03-30
4
P
0
700000
20.00
A
700000
I
By Logos Global Master Fund LP
All outstanding shares of Preferred Stock automatically converted into shares of Common Stock immediately upon the closing of the Issuer's initial public offering, for no additional consideration at a rate of one share of Common Stock for each 1.63 shares of Preferred Stock, based on the conversion price currently in effect. The Preferred Stock has no expiration date.
This Form 4 is being amended to correct the amount of securities beneficially owned by the Reporting Person. This error resulted in the misreporting of the amount of securities beneficially owned by the Reporting Person on subsequent reports.
Logos Global Management LP is the investment advisor of private funds, including Logos Opportunities Fund II LP ("LOF II") and Logos SPV 1 LP ("SPV 1"). Logos Opportunities GP LLC ("GP I") is the general partner of LOF II. Logos Opportunities II GP LLC ("GP II") is the general partner of SPV 1. The Reporting Person is the Managing Member of both GP I and GP II. The Reporting Person disclaims beneficial ownership of these securities except to the extent of Reporting Person's pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
Logos GP LLC ("Fund GP") is the general partner of Logos Global Master Fund LP (the "Fund"). The Reporting Person is the Managing Member of Fund GP. The Reporting Person disclaims beneficial ownership of these securities except to the extent of Reporting Person's pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
/s/ Mustapha Parekh, Attorney-in-Fact
2023-09-06